Diversify Wealth Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.77M Buy
33,976
+2,472
+8% +$169K 0.05% 314
2026
Q1
$1.99M Buy
31,504
+10,371
+49% +$731K 0.04% 384
2025
Q4
$1.51M Buy
21,133
+1,383
+7% +$93K 0.07% 247
2025
Q3
$1.31M Buy
19,750
+722
+4% +$48K 0.08% 239
2025
Q2
$1.22M Buy
19,028
+1,733
+10% +$98.6K 0.08% 248
2025
Q1
$1.05M Buy
17,295
+1,831
+12% +$106K 0.08% 237
2024
Q4
$816K Buy
15,464
+6,025
+64% +$309K 0.06% 250
2024
Q3
$480K Buy
9,439
+2,108
+29% +$121K 0.05% 325
2024
Q2
$382K Buy
+7,331
New +$322K 0.05% 320

Other funds holding HALO

Diversify Wealth Management's HALO Position: Q2 2026 in Review

Diversify Wealth Management increased its Halozyme (HALO) stake by 7.8% in Q2 2026, buying an estimated $169K and bringing the position to 33,976 shares worth $2.77M. The position accounts for 0.05% of the portfolio, ranked #314.

Diversify Wealth Management first reported a position in HALO in Q2 2024 and has held it in 9 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Diversify Wealth Management held 33,976 shares of Halozyme worth $2.77M as of Q2 2026.
  • Diversify Wealth Management bought 2,472 Halozyme shares in Q2 2026, an estimated $169K.
  • Halozyme made up 0.05% of Diversify Wealth Management's portfolio in Q2 2026, its #314 holding.
  • Diversify Wealth Management first reported a position in Halozyme in Q2 2024 and has held it in 9 quarters since.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Diversify Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.